Current Patterns of Management of Advanced Prostate Cancer in Routine Clinical Practice in Spain

Table 2

Treatment decisions for management of advanced prostate cancer.

	Value
Initial treatment for advanced or metastatic disease; (%)
Primary hormonal therapy	374 (99.7)
LHRH analogues	372 (99.5)
Nonsteroidal antiandrogens	306 (81.8)
Steroidal antiandrogens	12 (3.2)
Orchiectomy	5 (1.3)
Treatment for castration-resistant prostate cancer; (%)
Secondary hormonal therapy	139 (38.4)
First-line chemotherapy	135 (78.9)
Second-line chemotherapy	22 (13.1)
Palliative treatment	134 (37.4)

Patients may have received more than one therapeutic option. Percentages on the number of patients referred to the oncology unit for chemotherapy (). Missing data for the following variables: secondary hormonal therapy, ; first-line chemotherapy, ; second line chemotherapy, ; palliative treatment, . LHRH: luteinising hormone-releasing hormone.